Dr. Dubrovsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3800 Reservoir Rd., NW
Washington, DC 20007Phone+1 202-444-7599- Is this information wrong?
Summary
- Leonid Dubrovsky, MD, is a graduate of Jefferson University, College of Medicine. He completed his pediatric residency at Children’s National Medical Center and his hematology oncology fellowship at Memorial Sloan Kettering Cancer Center. Before joining the MedStar Georgetown staff as an assistant professor, Dr. Dubrovsky served on the Pediatric Hematology Oncology team at St. Jude Affiliate Clinic at Children’s Hospital in Baton Rouge.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Research, 2014 - 2015
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
- Children's National Medical CenterResidency, Pediatrics, 2007 - 2010
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2007
- Thomas Jefferson UniversityMD, 2007
Certifications & Licensure
- LA State Medical License 2016 - Present
- DC State Medical License 2010 - 2022
- NY State Medical License 2011 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 11 citationsLenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Josep M Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek-Yeol Ryoo, Zhenggang Ren, Gianluca Masi, Mariusz...> ;The Lancet. Oncology. 2023 Dec 1
- 26 citationsRandomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Am...Josep M Llovet, Arndt Vogel, David C Madoff, Richard S Finn, Sadahisa Ogasawara, Zhenggang Ren, Kalgi Mody, Jerry J Li, Abby B Siegel, Leonid Dubrovsky, Masatoshi Kudo> ;Cardiovascular and Interventional Radiology. 2022 Apr 1
- 596 citationsPhase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular CarcinomaRichard S. Finn, Masafumi Ikeda, Andrew X. Zhu, Max W. Sung, Ari David Baron, Masatoshi Kudo, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, Mar...> ;Journal of Clinical Oncology. 2020 Jul 27
- Join now to see all
Hospital Affiliations
- MedStar Georgetown University HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: